Objective: We evaluated the renoprotective effects as reflected by short-term changes in albuminuria of dual blockade of the renin-angiotensin system (RAS) by adding an angiotensin II receptor blocker ...

Ditching renin-angiotensin system (RAS) inhibitors in advanced chronic kidney disease (CKD) didn't help to slow kidney decline, according to the STOP ACEi trial. These findings were presented at the ...

A recent New England Journal of Medicine article proposed "endothelialitis" as the unifying mechanism for the widespread pathology of COVID-19. In a prior Medscape interview, Medscape contributor ...

Please provide your email address to receive an email when new articles are posted on . RAS blockers had similar mortality benefit by race in patients with HFrEF. RAS blockers improved HF ...

Angiotensin receptor blockers exhibited potential neuroprotective properties for reducing Parkinson disease (PD) risk in patients with newly diagnosed hypertension. A statistically significant ...